Duke University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Duke University sits in the top decile of US sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count).
Duke University: 1,725 sponsored US clinical trials, 187 recruiting.
Duke University sponsors 1,725 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 1,244 completed. 175 of these trials are in Phase 3-4 (later-stage) and 311 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
Duke University ranks in the top decile of sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,244 of 1,444 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,725 total, page 27 of 35
ENLIGHTEN: Exercise and NutritionaL Interventions for coGnitive and Cardiovascular HealTh ENhancement
NCT01573546
Isolation of Circulating Tumor Cells Using a Novel EMT-Based Capture Method
NCT02025413
Magnetic Resonance Imaging (MRI) in Motion
NCT02019199
Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes
NCT01377688
Prospective Randomized Evaluation of a Two and Three Piece Total Ankle Replacement
NCT01504438
Vasospasm in Pediatric Traumatic Brain Injury
NCT01461902
New Therapy for Patients With Severe Tinnitus
NCT01480193
Identifying the Genetic Predictors of Severe Acne Vulgaris and the Outcome of Oral Isotretinoin Treatment
NCT01727440
Improving Emergency Department Management of Adults With Sickle Cell Disease
NCT01603160
RESULT (REflux Surgery in Lung Transplantation) Preliminary Study Protocol
NCT01406210
Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip
NCT01759550
Right Ventricular (RV) Pacing in Early Post-operative Continuous Flow Left Ventricular Assist Device (LVAD)
NCT01446796
Dose-varied Evaluation of Ablavar-enhanced MR Angiography of the Central Veins of the Chest in Healthy Participants
NCT01431300
Meclizine as a Potential Smoking Cessation Treatment
NCT01443858
Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI)
NCT01450800
Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer
NCT01207102
Patient and Provider Interventions for Managing Osteoarthritis in Primary Care
NCT01435109
Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women
NCT01385241
Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation
NCT01406223
Milnacipran and Neurocognition, Pain and Fatigue in Fibromyalgia : A 13-week Randomized, Placebo Controlled Cross Over Trial
NCT01829243
Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo
NCT01419977
Statin Therapy to Improve Medication Adherence
NCT01894217
Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia
NCT02151253
Mindfulness-based Personalized Health Planning for Reducing Risk of Heart Disease and Diabetes
NCT01430221
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
NCT01309659
Sildenafil in Single Ventricle Patients
NCT01169519
Mila Blooms Intervention Study
NCT01473342
Cognitive Behavioral Treatments for Depression in Chronic Illness
NCT01208428
A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins
NCT01372631
Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)
NCT01186406
Concurrent Bupropion / Varenicline for Smoking Cessation
NCT01303861
Patient Positioning in Lumbar Fusion Surgery and Its Impact on Spinal Sagittal Balance and Surgeon Satisfaction
NCT01326091
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection
NCT01191840
Impact of Blood Storage Duration on Physiologic Measures
NCT01274390
Steps to Health: Targeting Obesity in the Health Care Workplace
NCT01299051
Ehealth: Second Life Impacts Diabetes Education & Self-Management
NCT01186965
Pacing Affects Cardiovascular Endpoints in Patients With Right Bundle-Branch Block (The PACE-RBBB Trial)
NCT01169493
Open Label Use Of RiaStap During Aortic Reconstruction
NCT01300286
Personalized Cardiovascular Risk Information to Initiate and Maintain Health Behavior Changes
NCT01134458
The Effects of Respiratory Muscle Strength Training (RMST) on Inspiratory and Expiratory Muscle Strength in Adults and Children With Pompe Disease
NCT01701154
Early Intervention for Morbidly Obese Patients After Roux-en-Y Gastric Bypass (RYGB) Surgery
NCT01329692
Educational Videos to Improve Patient Decision Making and Race Disparities in Implantable Cardioverter Defibrillator Use
NCT00918125
Cell Phone Intervention in Young Adults
NCT01092364
Intervention Study of Communication in Oncologist-Patient Encounters
NCT00994578
Open-label Milnacipran for Persistent Knee Pain One Year After Total Knee Arthroplasty (TKA)
NCT01780389
Cognitive Remediation in 22q11DS
NCT01781923
Reduced Radiation in Patients With Diffuse Large B-cell Lymphoma
NCT01186978
Stress Reduction Training to Improve Sleep Quality, Stress Physiology & Cardiovascular Disease (CVD) Risk Markers
NCT01343810
Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma
NCT01108445
Esmolol for Treatment of Perioperative Tachycardia
NCT01208402
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 136 |
| Phase 2 | 175 |
| Phase 3 | 41 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Duke University pipeline
187 recruiting of 1,725 indexed (11% open); 1,244 completed (72%).
Phase mix: 175 late (III/IV) vs 311 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Duke University: open-pipeline peers nationwide
Peers matched on 1,725 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Duke University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,725 trials (± recruiting share)
- University of California, San Francisco · 1,713 trials · 16% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Carnegie Mellon University · 11% recruiting · 37 trials
- CAMC Health System · 11% recruiting · 28 trials
- UConn Health · 11% recruiting · 178 trials
- Hartford Hospital · 11% recruiting · 75 trials
Related
What to do with this Duke University page
1,725 registered trials is a research-attention snapshot, not an endorsement of Duke University or any single study.
- 187 of Duke University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Duke University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Duke University pipeline card: 1,725 registered trials from official public datasets.Report a data error.